Omada Health added to ‘Tactical Outperform’ list at Evercore ISI

Group 1 - Evercore ISI analyst Elizabeth Anderson has added Omada Health (OMDA) to the firm's "Tactical Outperform" list as part of an update on estimates and tactical calls in the Healthcare Technology & Distribution group ahead of Q3 earnings season [1] - The firm maintains an Outperform rating on Omada shares with a price target set at $27 [1]